Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Persistent Bronchial Asthma”

39 trials

Showing 20 of 39 results

Large-scale testing (Phase 3)Study completedNCT00401596
What this trial is testing

Evaluate the Safety of Xolair in Moderate to Severe Persistent Asthma Patients (ALTO)

Who this might be right for
Asthma
Genentech, Inc. 1,899
Testing effectiveness (Phase 2)Ended earlyNCT02219048
What this trial is testing

An Evaluation Of PF-03715455 In Moderate To Severe Uncontrolled Asthma

Who this might be right for
Asthma
Pfizer 51
Testing effectiveness (Phase 2)Study completedNCT01070524
What this trial is testing

Cross-over Study to Evaluate the Effect on Trough Forced Expiratory Volume in One Second (FEV1) After 4 Weeks Treatment With CHF 5188 pMDI qd in Adult Patients With Persistent Asthma

Who this might be right for
Asthma
Chiesi Farmaceutici S.p.A. 113
Testing effectiveness (Phase 2)Looking for participantsNCT07342803
What this trial is testing

Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients

Who this might be right for
Allergic Asthma
Longbio Pharma 200
Not applicableStudy completedNCT01055041
What this trial is testing

Controller Medications in the Management of Bronchial Asthma

Who this might be right for
Moderate to Severe Persistent Bronchial Asthma
Government Medical College, Bhavnagar 50
Testing effectiveness (Phase 2)Study completedNCT00280683
What this trial is testing

Effects of L-arginine Supplementation in Adults With Moderate to Severe Asthma

Who this might be right for
Asthma
University of California, Davis 20
Testing effectiveness (Phase 2)Study completedNCT00141791
What this trial is testing

Study Evaluating Etanercept in Moderate to Severe Asthma

Who this might be right for
Asthma
Wyeth is now a wholly owned subsidiary of Pfizer 120
Large-scale testing (Phase 3)Study completedNCT01511367
What this trial is testing

Comparison of Flutiform, Fluticasone and Seretide in Treatment of Moderate to Severe Asthma in Paediatric Patients

Who this might be right for
Asthma
Mundipharma Research Limited 498
Large-scale testing (Phase 3)Study completedNCT01202903
What this trial is testing

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Who this might be right for
Persistent Allergic Asthma
Novartis Pharmaceuticals 616
Large-scale testing (Phase 3)Study completedNCT04607629
What this trial is testing

An Efficacy and Safety Study of Genolar® and Xolar® in the Persistent Atopic Bronchial Asthma

Who this might be right for
Bronchial Asthma
AO GENERIUM 192
Large-scale testing (Phase 3)Study completedNCT00413387
What this trial is testing

Efficacy and Tolerability of Beclomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI Via HFA-134a Vs. Budesonide 160 µg + Formoterol 4,5 µg Dry Powder Via Turbuhaler®. (Symbicort®)

Who this might be right for
Bronchial Asthma
Chiesi Farmaceutici S.p.A. 219
Large-scale testing (Phase 3)Study completedNCT00476268
What this trial is testing

Efficacy and Tolerability of Beclometasone/Formoterol Single Inhaler in Patients With Moderate to Severe Persistent Asthma

Who this might be right for
Asthma
Chiesi Farmaceutici S.p.A. 824
Large-scale testing (Phase 3)Study completedNCT04233190
What this trial is testing

A Multicenter, Randomized, Parallel, Two-period, Non-inferiority Study of EurofarmavsAlenia in Asthma and COPD Treatment

Who this might be right for
Asthma Copd
Eurofarma Laboratorios S.A. 472
Testing effectiveness (Phase 2)Study completedNCT01312961
What this trial is testing

Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma

Who this might be right for
Asthma
Sanofi 104
Large-scale testing (Phase 3)Study completedNCT00563056
What this trial is testing

An Open, Randomised, Parallel Group Multicentre Study to Compare the Efficacy and Safety of Flutiform® pMDI vs Fluticasone pMDI Plus Formoterol DPI in Adolescent and Adult Subjects With Mild to Moderate-severe Persistent, Reversible Asthma

Who this might be right for
Asthma Bronchiale
Mundipharma Research Limited 227
Testing effectiveness (Phase 2)Study completedNCT00330070
What this trial is testing

Control of Asthma Patients Symptomatic on Inhaled Corticosteroids

Who this might be right for
Asthma
Inflazyme Pharmaceuticals Ltd 200
Post-approval studies (Phase 4)Study completedNCT00670930
What this trial is testing

Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists

Who this might be right for
Allergic Asthma
Novartis Pharmaceuticals 36
Large-scale testing (Phase 3)Study completedNCT00254956
What this trial is testing

Effects Of Ciclesonide And Beclomethasone On Lens Opacification In Adult Subjects With Moderate To Severe Persistent Asthma

Who this might be right for
Respiratory Tract DiseasesRespiratory HypersensitivityAsthma
Sanofi 1,568
Testing effectiveness (Phase 2)Study completedNCT01311661
What this trial is testing

Compare the Efficacy and Safety of Different Dosings of Olodaterol Administered With the Respimat® Inhaler in Patients With Moderate to Severe Asthma

Who this might be right for
Asthma
Boehringer Ingelheim 206
Testing effectiveness (Phase 2)Study completedNCT01437735
What this trial is testing

Dose Finding Study for QAW039 in Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 1,043
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation